Skeletal Dysplasia: Difference between revisions

mNo edit summary
No edit summary
Line 32: Line 32:


=== Skeletal dysplasia Classification ===
=== Skeletal dysplasia Classification ===
The first 8 groups of conditions in the 2010 nosology are separated according to the molecular basis of the disease: ''FGFR3'', type 2 collagen, type 11 collagen, sulfation disorders, perlecan, aggrecan, filamin, and ''TRPV4''. The other 32 groups are organized according to their clinical and radiographic presentation. The prefix ''acro-'' refers to the extremities (hands and feet), meso- to the middle portion (ulna and radius, tibia and fibula), ''rhizo-'' to the proximal portion (femur and humerus), ''spondylo-'' to the spine, ''epi-'' to the epiphyses, and ''meta-'' to the metaphyses. For example, if only the hands and feet are shorter, one would consult the acromelic group of conditions, whereas if the spine and metaphyses are affected, one would consult the spondylometaphyseal dysplasias. Listed below are the 40 groups of conditions to be detailed in this chapter.
The first 8 groups of conditions in the 2010 nosology are separated according to the molecular basis of the disease: ''FGFR3'', type 2 collagen, type 11 collagen, sulfation disorders, perlecan, aggrecan, filamin, and ''TRPV4''.  
 
The other 32 groups are organized according to their clinical and radiographic presentation. The prefix ''acro-'' refers to the extremities (hands and feet), meso- to the middle portion (ulna and radius, tibia and fibula), ''rhizo-'' to the proximal portion (femur and humerus), ''spondylo-'' to the spine, ''epi-'' to the epiphyses, and ''meta-'' to the metaphyses. For example, if only the hands and feet are shorter, one would consult the acromelic group of conditions, whereas if the spine and metaphyses are affected, one would consult the spondylometaphyseal dysplasias.  


'''Groups of conditions organized according to their molecular bases;'''
'''Groups of conditions organized according to their molecular bases;'''


# ''FGFR3'' chondrodysplasia group
* ''FGFR3'' chondrodysplasia group
# Type 2 collagen group and similar disorders
* Type 2 collagen group and similar disorders
# Type 11 collagen group
* Type 11 collagen group
# Sulfation disorders group
* Sulfation disorders group
# Perlecan group
* Perlecan group
# Aggrecan group
* Aggrecan group
# Filamin group and related disorders
* Filamin group and related disorders
# ''TRPV4'' group      
* ''TRPV4'' group


'''Conditions can be grouped based on their clinical presentations;'''
'''Conditions can be grouped based on their clinical presentations;'''
Line 79: Line 81:
; 31. Polydactyly-Syndactyly-Triphalangism group
; 31. Polydactyly-Syndactyly-Triphalangism group
; 32. Defects in joint formation and synostoses
; 32. Defects in joint formation and synostoses
== References  ==
== References  ==


<references />
<references />

Revision as of 16:44, 4 April 2024

Original Editor - User Name

Top Contributors - Ayodeji Mark-Adewunmi and Kim Jackson  

Introduction[edit | edit source]

Skeletal dysplasias also termed as osteochondrodysplasias are a large heterogeneous group of disorders comprising of abnormalities of bone or cartilage growth or texture. Skeletal dysplasia is a group of rare genetic disorders that affect bone growth and development. These disorders are characterized by abnormalities in the size, shape, and structure of bones, resulting in short stature, limb deformities, and other skeletal abnormalities.

They occur due to genetic mutations and their phenotype continues to evolve throughout life. Skeletal dysplasias thus differ from dysostoses which are malformations of single or multiple bones in combination, are due to abnormal blastogenesis in-utero and phenotypically remain static throughout life.[1]

Epidemiology[edit | edit source]

About 1 in 5,000 babies are born with some type of skeletal dysplasia.[2] Nonetheless, if taken collectively, genetic skeletal dysplasias or osteochondrodysplasias comprise a recognizable group of genetically determined disorders with generalized skeletal affection.

Etiology[edit | edit source]

Skeletal dysplasia is caused by mutations in genes that are responsible for bone growth and development. These mutations can be inherited from one or both parents, or they can occur spontaneously during fetal development.

Clinical Signs and Symptoms[edit | edit source]

The symptoms of skeletal dysplasia can vary widely depending on the specific type of disorder and the severity of the condition. However, some common symptoms include:

Short stature: Individuals with skeletal dysplasia are typically shorter than average for their age and gender.

Limb deformities: Skeletal dysplasia can cause abnormalities in the size and shape of the limbs, including bowed legs, knock-knees, and curved spine.

Joint pain: Skeletal dysplasia can cause joint pain and stiffness, particularly in the hips and knees.

Breathing difficulties: In some cases, skeletal dysplasia can cause narrowing of the airways, leading to breathing difficulties.

Dental abnormalities: Some types of skeletal dysplasia can cause abnormalities in the teeth, including missing or misshapen teeth.

Skeletal dysplasia Classification[edit | edit source]

The first 8 groups of conditions in the 2010 nosology are separated according to the molecular basis of the disease: FGFR3, type 2 collagen, type 11 collagen, sulfation disorders, perlecan, aggrecan, filamin, and TRPV4.

The other 32 groups are organized according to their clinical and radiographic presentation. The prefix acro- refers to the extremities (hands and feet), meso- to the middle portion (ulna and radius, tibia and fibula), rhizo- to the proximal portion (femur and humerus), spondylo- to the spine, epi- to the epiphyses, and meta- to the metaphyses. For example, if only the hands and feet are shorter, one would consult the acromelic group of conditions, whereas if the spine and metaphyses are affected, one would consult the spondylometaphyseal dysplasias.

Groups of conditions organized according to their molecular bases;

  • FGFR3 chondrodysplasia group
  • Type 2 collagen group and similar disorders
  • Type 11 collagen group
  • Sulfation disorders group
  • Perlecan group
  • Aggrecan group
  • Filamin group and related disorders
  • TRPV4 group

Conditions can be grouped based on their clinical presentations;

1. Short-ribs dysplasias (with or without polydactyly) group
2. Multiple epiphyseal dysplasia and pseudoachondroplasia group
3. Metaphyseal dysplasias
4. Spondylometaphyseal dysplasias (SMD)
5. Spondylo-epi-(meta)-physeal dysplasias (SE(M)D)
6. Severe spondylodysplastic dysplasias
7. Acromelic dysplasias (extremities of the limbs)
8. Acromesomelic dysplasias (extremities and middle portion of the limbs)
9. Mesomelic and rhizo-mesomelic dysplasias (proximal and middle portions of the limbs)
10. Bent bones dysplasias
11. Slender bone dysplasia group
12. Dysplasias with multiple joint dislocations
13. Chondrodysplasia punctata (CDP) group
14. Neonatal osteosclerotic dysplasias
15. Increased bone density group (without modification of bone shape)
16. Increased bone density group with metaphyseal and/or diaphyseal involvement
17. Osteogenesis imperfecta and decreased bone density group
18. Abnormal mineralization group
19. Lysosomal storage diseases with skeletal involvement (dysostosis multiplex group)
20. Osteolysis group
21. Disorganized development of skeletal components group
22. Overgrowth syndromes with skeletal involvement
23. Genetic inflammatory/rheumatoid-like osteoarthropathies
24. Cleidocranial dysplasia and isolated cranial ossification defects group
25. Craniosynostosis syndromes
26. Dysostoses with predominant craniofacial involvement
27. Dysostoses with predominant vertebral with and without costal involvement
28. Patellar dysostoses
29. Brachydactylies (with or without extraskeletal manifestations)
30. Limb hypoplasia-reduction defects group
31. Polydactyly-Syndactyly-Triphalangism group
32. Defects in joint formation and synostoses

References[edit | edit source]

  1. Offiah AC, Hall CM. Radiological diagnosis of the constitutional disorders of bone. As easy as A, B, C?. Pediatric radiology. 2003 Mar;33:153-61.
  2. Geister KA, Camper SA. Advances in skeletal dysplasia genetics. Annual review of genomics and human genetics. 2015 Aug 24;16:199-227.